Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BEVACIZUMAB for K-ras gene mutation: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 19 adverse event reports in the FDA FAERS database where BEVACIZUMAB was used for K-ras gene mutation.

Most Reported Side Effects for BEVACIZUMAB

Side Effect Reports % Deaths Hosp.
Off label use 12,094 15.5% 3,560 1,814
Death 8,493 10.9% 8,485 726
Diarrhoea 4,911 6.3% 1,110 1,932
Disease progression 4,653 6.0% 1,838 749
Fatigue 4,572 5.9% 1,358 1,294
Nausea 4,357 5.6% 1,050 1,459
Hypertension 4,309 5.5% 534 1,181
Anaemia 3,221 4.1% 587 1,289
Vomiting 3,193 4.1% 794 1,404
Neutropenia 2,875 3.7% 449 720
Pyrexia 2,602 3.3% 512 1,618
Decreased appetite 2,559 3.3% 682 944
Asthenia 2,489 3.2% 790 924
Drug ineffective 2,488 3.2% 493 369
Proteinuria 2,384 3.1% 325 459

Other Indications for BEVACIZUMAB

Product used for unknown indication (9,041) Hepatocellular carcinoma (7,773) Colorectal cancer metastatic (5,474) Ovarian cancer (5,283) Non-small cell lung cancer (4,136) Colon cancer (4,015) Colorectal cancer (2,788) Breast cancer (2,130) Lung neoplasm malignant (1,810) Glioblastoma (1,610)

Other Drugs Used for K-ras gene mutation

SOTORASIB (752) AMG-510 (173) IRINOTECAN (40) PANITUMUMAB (36) CETUXIMAB (29) PEMBROLIZUMAB (28) DALOTUZUMAB (18) CARBOPLATIN (17) FLUOROURACIL (17) PEMETREXED (16)

Related Pages

BEVACIZUMAB Full Profile All K-ras gene mutation Drugs BEVACIZUMAB Demographics BEVACIZUMAB Timeline